Notice of Call of the Extraordinary Shareholders' Meeting
Shareholders are called to the Shareholders' Meeting, in extraordinary session, in first call, on 26th July 2022 at 11:00 a.m., and, if necessary
Notice of Call of the Shareholders' Meeting
Shareholders are called to the Shareholders' Meeting, in first call, on 29 April 2022 at 11:00 a.m., and, if necessary, on 20 May 2022, in second call,
Gefran S p A : 08-30-2021 PROXY FORM TO THE DESIGNATED REPRESENTATIVE marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Cassiopea announces results of AGM 2021
Search jobs
Cassiopea S.p.A. / Key word(s): Miscellaneous
29-Apr-2021 / 18:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.
Pierpaolo Guzzo is following on Jan de Vries as Chairman
Lainate - April 29, 2021 - Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced the results of its Annual General Meeting held today on April 29, 2021 in Lainate, Milan (Italy).
Owing to the COVID-19 health emergency and in compliance with art. 106 of Law Decree n. 18 dated March 17, 2020, converted into Law n. 27 dated April 24, 2020 (as last amended by Law-Decree n. 183 dated December 20, 2020, converted with amendments into Law n. 21 dated February 26, 2021) aimed at minimizing travel
Lists of candidates for the board of directors at the AGM 2021
Cassiopea S.p.A. / Key word(s): Miscellaneous
21-Apr-2021 / 07:01 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.
Lainate - April 21, 2021 - Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, today announced the lists of candidates proposed for the board of directors at the Annual General Meeting of 29 April 2021, in Lainate, Milan (Italy).
The list proposed by Cassiopea s shareholder Cosmo Pharmaceuticals NV consists of the following candidates: Pierpaolo Guzzo (incumbent, executive), Jan de Vries (incumbent, non-executive, independent), Diana Harbort (incumbent, executive) and Oyvind Bjordal (incumbent, non-executive, independent